GoodRx Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	800.65	792.32	750.27	766.55	745.42	550.7
Revenue Growth (YoY)	1.30%	5.61%	-2.13%	2.83%	35.36%	41.85%
Cost of Revenue	52.33	48.22	62.43	65.08	46.72	29.59
Gross Profit	748.33	744.11	687.84	701.48	698.71	521.11
Selling, General & Admin	435.58	464.62	450.41	484.37	524.9	714.52
Research & Development	123.83	123.75	126.44	143.14	125.86	61.82
Operating Expenses	640.57	657.91	637.82	681.68	685.3	794.76
Operating Income	107.76	86.2	50.02	19.8	13.41	-273.65
Interest Expense	-43.56	-52.92	-56.73	-34.24	-23.64	-27.91
Interest & Investment Income	13.63	23.27	32.17	9.27	0.06	0.16
Other Non Operating Income (Expenses)	0.69	-2.66	-	-	-	0.02
EBT Excluding Unusual Items	78.52	53.89	25.47	-5.17	-10.18	-301.38
Merger & Restructuring Charges	-7.36	-7.36	-76.93	-	-	-
Gain (Loss) on Sale of Investments	-	-	-4.01	-	-	-
Legal Settlements	-13	-13	-0.1	-	-	-
Other Unusual Items	-	-2.08	-	-18.06	-	-2.07
Pretax Income	53.75	31.46	-55.57	-23.23	-10.18	-303.45
Income Tax Expense	22	15.07	-46.7	9.6	15.08	-9.83
Net Income	31.75	16.39	-8.87	-32.83	-25.25	-293.62
Net Income to Common	31.75	16.39	-8.87	-32.83	-25.25	-293.62
Shares Outstanding (Basic)	367	386	410	413	410	275
Shares Outstanding (Diluted)	368	392	410	413	410	275
Shares Change (YoY)	-5.60%	-4.42%	-0.62%	0.70%	49.25%	18.81%
EPS (Basic)	0.09	0.04	-0.02	-0.08	-0.06	-1.07
EPS (Diluted)	0.09	0.04	-0.02	-0.08	-0.06	-1.07
Free Cash Flow	177.32	182.65	137.25	142.81	174.21	110.79
Free Cash Flow Per Share	0.48	0.47	0.33	0.35	0.42	0.40
Gross Margin	93.47%	93.92%	91.68%	91.51%	93.73%	94.63%
Operating Margin	13.46%	10.88%	6.67%	2.58%	1.80%	-49.69%
Profit Margin	3.97%	2.07%	-1.18%	-4.28%	-3.39%	-53.32%
Free Cash Flow Margin	22.15%	23.05%	18.29%	18.63%	23.37%	20.12%
EBITDA	132.72	99.54	67.09	47.57	35.75	-259.62
EBITDA Margin	16.58%	12.56%	8.94%	6.21%	4.79%	-47.14%
D&A For EBITDA	24.97	13.34	17.07	27.78	22.34	14.03
EBIT	107.76	86.2	50.02	19.8	13.41	-273.65
EBIT Margin	13.46%	10.88%	6.67%	2.58%	1.80%	-49.69%
Effective Tax Rate	40.93%	47.90%	-	-	-	-
Advertising Expenses	-	211.4	198.8	226.3	296.6	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q